What is a PGx Test and Genomic Medicine?

What is a PGx test, and how does it fit into genomic medicine? In short, it is a one-time DNA test that shows how your genes may affect the way you process certain medications, so you and your prescriber can make better informed choices from the start.

The history of medication has been working around trials and errors. This not only has proven to sometimes aggravate the condition but even deaths have occurred due to the trials in medications. There has always been a need for medications that don’t affect individuals in a way that worsens their condition. This was only possible if the medications were based on your DNA.

Pharmacogenetics is the study of how a person’s genes affect how they respond to drugs. It’s also known as pharmacogenomics, but what is a PGx test? Pharmacogenomics test commonly known as a PGx test provides you with targeted genomic information (insights into selected genes that affect how your body handles medications). Genomic Medicine, also known as personalized medicine, is the use of genomic information to improve the diagnosis and treatment of medical conditions.

Genomic Medicine in Depth

Genomic medicine integrates DNA information to enhance the diagnosis and treatment of various medical conditions. By uncovering the genetic basis of diseases, healthcare providers can prescribe tailored medications and dosages, improving treatment effectiveness and reducing adverse effects. This approach has proven particularly beneficial in therapeutic areas such as:

• Oncology: Optimizing cancer treatments based on tumor genetics.
• Cardiology: Customizing heart medications to avoid harmful side effects.
• Psychiatry: Addressing the unique genetic factors influencing mental health treatments.

Genomic Medicine and Mental Health

In mental health, pharmacogenomic testing plays a vital role in optimizing medication therapy. Genetic variations can significantly impact how individuals metabolize and respond to psychiatric medications, affecting their efficacy and the likelihood of side effects. By utilizing insights from genomic medicine, clinicians can bypass the traditional trial-and-error process, prescribing treatments that are more likely to be effective from the outset.

FDA-Labelled Genome-Based Medications

The U.S. Food and Drug Administration (FDA) emphasizes the role of pharmacogenomics in improving drug safety and efficacy, and many medications, including some mental health medications, carry pharmacogenomic information in their labeling. Three well-known examples from outside mental health are:

1. Warfarin: An anticoagulant, warfarin’s effectiveness and safety are influenced by variations in the CYP2C9 and VKORC1 genes. These genetic differences can affect drug metabolism and sensitivity, requiring dosage adjustments – failure to do so can lead to bleeding risks.
2. Clopidogrel: An antiplatelet medication, clopidogrel requires activation by the CYP2C19 enzyme. As per the boxed warning, consider using another platelet P2Y12 inhibitor in patients who are poor metabolizers of CYP2C19.
3. Codeine: A pain reliever, codeine is metabolized into morphine by the CYP2D6 enzyme. Individuals who are ultra-rapid metabolizers of this enzyme may experience enhanced effects, including an increased risk of toxicity. According to the FDA-label, “individuals who are ultra-rapid metabolizers may have life-threatening or fatal respiratory depression or experience signs of overdose (such as extreme sleepiness, confusion, or shallow breathing).”

Genome-Based vs. Non-Genome-Based Medications

Traditional approaches to prescribing medications often involve trial and error, which can take more time, cost more, and carry a higher risk of adverse outcomes. Genomic medicine, by contrast, uses genetic insights to streamline this process and achieve better results.

Aspect	Non-Genome-Based Medications	Genome-Based Medications
Approach	Trial and error	Personalized based on genetics
Time to Effective Treatment	Prolonged due to multiple trials	Shorter, with targeted therapy
Cost	Higher due to repeated visits	Lower by avoiding ineffective treatments
Health Outcomes	Variable; risk of adverse effects	Improved efficacy and fewer side effects

At-Home Pharmacogenomic Testing by RPh Labs

RPh Labs offers non-invasive at-home pharmacogenomic (PGx) testing kits that provide insights into how individuals may respond to 240+ medications. Our PGx tests require only a cheek swab sample, making them safe and easier for users.

The results of PGx tests can help:

• Avoid medications that could cause adverse reactions.
• Identify drugs best suited to an individual’s genetic profile.
• Optimize dosages based on genetic metabolism.
• Minimize the trial-and-error approach to finding effective treatments.

While these tests provide valuable insights, it’s essential to consult with a healthcare provider before making treatment decisions.

What is a PGx test actually measuring?

A PGx test does not read your whole genome. It looks at a targeted set of genes that are known to affect how medications are absorbed, activated, broken down or removed from the body. Within those genes, the lab checks for specific, well-studied variants.

Those variants are grouped into named versions of each gene, called star alleles, such as CYP2D6*1 or CYP2C19*2. The official naming system is maintained by PharmVar. You inherit one copy of each gene from each parent, so your result for a gene is a pair of star alleles, called a diplotype.

The lab then translates each diplotype into something a prescriber can use, usually a predicted metabolizer status or a predicted level of function. That translation step is what turns raw genetic data into useful information for everyday care.

Because your DNA does not change, the genotype part of a PGx test only needs to be done once. What can change over time is the guidance attached to it, as researchers learn more and professional guidelines are updated.

How genomic medicine turns DNA into a prescribing plan

Genomic medicine is not a single test result. It is a process that moves from your sample to a decision you make together with your prescriber. Knowing the steps helps you understand why a report looks the way it does.

1. Genotyping: the lab identifies which variants you carry in each gene on the panel.
2. Interpretation: each genotype is assigned a predicted phenotype, such as normal, intermediate or poor metabolizer.
3. Guideline matching: the phenotype is compared with published recommendations, such as the CPIC guidelines and FDA drug labeling.
4. Clinical decision: your prescriber weighs the genetic information alongside your age, kidney and liver function, other medications and health history.

Much of the guidance behind genomic medicine is public. CPIC publishes peer-reviewed, gene-by-drug recommendations, and PharmGKB collects the research behind them. When a lab reports that a result is actionable, it usually means a guideline or drug label recommends a specific adjustment for that result.

The last step matters most. Genomic medicine adds one important input to a prescribing decision, but it never replaces the clinical judgment of the person who knows your full health picture. If you want a deeper overview of the testing side, read our guide on what PGx testing involves.

Reading your pgx test results: metabolizer status explained

Most pgx test results for drug-metabolizing enzymes use the same five categories. Your metabolizer status describes how active a particular enzyme is predicted to be, based on your genes.

• Poor metabolizer: little or no enzyme activity. Drugs cleared by that enzyme can build up, while prodrugs that need the enzyme to become active may not work well.
• Intermediate metabolizer: reduced activity. Some medications may need a dose change or closer monitoring.
• Normal metabolizer: typical activity. Standard dosing usually applies.
• Rapid metabolizer: somewhat increased activity, reported for genes such as CYP2C19.
• Ultrarapid metabolizer: much higher activity. Some drugs may be cleared too fast, while prodrugs may be activated too quickly.

Not every gene uses these labels. Transporter genes such as SLCO1B1 are reported as normal, decreased or poor function. Immune genes such as HLA-B are reported as positive or negative for a specific variant. Your metabolizer status is gene specific, so you can be a normal metabolizer for one enzyme and a poor metabolizer for another.

Which genes on a PGx panel matter for common medications

Panels differ between labs. The RPh Labs panel covers 20 genes and reports on more than 240 medications. A few examples show how the genes connect to everyday prescriptions:

• CYP2D6: activates codeine and tramadol and helps clear many antidepressants and antipsychotics.
• CYP2C19: activates clopidogrel and clears several SSRIs and proton pump inhibitors.
• CYP2C9 and VKORC1: together guide warfarin dosing.
• SLCO1B1: decreased function raises the risk of muscle problems with simvastatin.
• TPMT and NUDT15: variants increase the risk of serious side effects from thiopurines such as azathioprine.
• DPYD: reduced function raises toxicity risk with fluorouracil and capecitabine.

You can browse the full medication list by gene to see whether any of your current or planned prescriptions have a known gene connection. The FDA also keeps a public table of pharmacogenomic biomarkers in drug labeling.

Personalized medicine beyond mental health

Mental health gets a lot of attention in PGx discussions, but personalized medicine based on genetics reaches into many other areas of care. Several of the strongest gene and drug pairs have nothing to do with psychiatry.

• Heart and blood vessels: clopidogrel after a stent, warfarin for clots and simvastatin for cholesterol all have well-established genetic guidance.
• Pain: CYP2D6 affects how codeine and tramadol are turned into their active forms, which influences both relief and risk.
• Cancer care: DPYD, TPMT, NUDT15 and UGT1A1 results can guide dosing of certain chemotherapy drugs.
• Neurology: people who carry HLA-B*15:02 have a higher risk of severe skin reactions to carbamazepine.

This is why a single PGx test can stay useful for years. A result ordered for an antidepressant decision may later help your cardiologist, surgeon or oncologist. Personalized medicine works best when your results travel with you and are part of your medical record.

What a PGx test cannot tell you

Knowing the limits of a PGx test helps you set realistic expectations. Genetics explains part of the variation in how people respond to drugs, not all of it.

• It does not diagnose a disease or tell you which condition you have.
• It cannot predict every side effect, because diet, alcohol, smoking, age and organ function also play a role.
• It does not account for drug interactions. Medications such as fluoxetine, paroxetine and bupropion can block CYP2D6 and make a normal metabolizer act like a poor one, which is called phenoconversion.
• It only covers the genes and variants on the panel. Rare variants that are not tested can still exist.

It is also worth knowing that a normal result is still useful. Learning that you are a normal metabolizer for CYP2D6 or CYP2C19 tells your prescriber that standard dosing is a reasonable starting point for many common drugs, which can make decisions simpler and more confident.

Because of these limits, PGx information is best treated as one piece of the puzzle. Your prescriber combines it with how you are actually responding to a medication. Our article on CYP2D6 inhibitors explains phenoconversion in more detail.

How to use pgx test results with your prescriber

Getting a report is only useful if it reaches the people who prescribe for you. A few simple habits make pgx test results much more practical.

1. Share a copy of the full report with your primary care provider and ask that it be added to your chart.
2. Bring an up-to-date list of every medication and supplement you take, since interactions can change how your genes play out.
3. Ask which of your current medications, if any, have guidance related to your results.
4. Do not stop or change a medication on your own. Any change should be planned with your prescriber.
5. Keep a copy for future visits, pharmacies and specialists.

If your prescriber is new to PGx, point them to our resources for providers. RPh Labs reports are reviewed by a PharmD pharmacist, and a free pharmacist consultation is included to help you understand the findings.

What is a PGx test like from start to finish at home?

Many people picture a blood draw, but an at-home PGx test is simpler. The RPh Labs kit uses a cheek (buccal) swab, not a blood sample. You rub the swab on the inside of your cheek, seal it and send it back in the prepaid mailer.

Results are ready 7 to 10 business days after your sample reaches our CLIA-certified laboratory in Dallas, Texas. The self-pay price is $299 with free shipping both ways, and the kit is HSA/FSA eligible. You can also split the cost into 4 interest-free installments, and insurance, including Medicare, is accepted in many cases.

You can see each step on our how it works page or order the at-home PGx kit when you are ready. If you are unsure whether testing makes sense for you, talk it over with your prescriber first.

Conclusion

The answer to “What is a PGx test” is simple, it’s a test that gives insights into selected genes that affect how you respond to medications. Medicine based on this data is called genomic medicine or personalized medicine. These personalized medications reduce trials & errors and perhaps have higher efficacy. If you or your loved ones are going through mental health medication or about to start a blood thinner such as warfarin, talking to a doctor about taking a PGx test before may be vital – here is how it works.

References:

• FDA

Disclaimer: This blog is only for informational purposes. Please always consult a doctor before taking any medical action.

What is a PGx test FAQ

Do I need a new PGx test every few years?

No. Your genes do not change, so the genotype from a PGx test stays valid for life. What can change is the guidance linked to your results as new research and guidelines appear. RPh Labs updates reports when guidelines change, so it is worth checking in with your prescriber before starting a new medication.

Can my metabolizer status change if I start a new drug?

Your genetic metabolizer status stays the same, but your real-world enzyme activity can change. Some medications, such as fluoxetine, paroxetine and bupropion, block CYP2D6 and can make a normal metabolizer behave like a poor one. Always share your full medication list with your prescriber so they can factor this in.

Is genomic medicine only for people with a serious illness?

No. Genomic medicine is useful for anyone taking, or likely to take, medications with known gene interactions. That includes common drugs for depression, pain, heart disease and high cholesterol. Many people test before a new prescription or after side effects with a previous one.

Who should see my pgx test results?

Share them with your primary care provider, any specialists who prescribe for you and your pharmacist. The more of your care team that has the report, the more likely it is to be used when a new prescription is written. Keep your own copy as well.

Is personalized medicine the same as a DNA ancestry test?

No. Ancestry tests look at markers related to family origins and are not designed for prescribing. A PGx test from a CLIA-certified lab looks at specific medication-related genes and reports results in a format your prescriber can use to guide medication choices.

Does a PGx test replace talking to my doctor?

No. A PGx report is one input into a medication decision. Your prescriber still considers your age, weight, kidney and liver function, other medications and how you respond to treatment. Use the results as a starting point for a better conversation, not as a reason to change medication on your own.